Reactions Weekly

, Volume 1697, Issue 1, pp 212–212 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 3 case reports
Case report
  • 18 Downloads

Reference

  1. Johnson C, et al. Diagnosis and Management of Immune Checkpoint Inhibitor-related Toxicities in Ovarian Cancer: A Series of Case Vignettes. Clinical Therapeutics 40: 389-394, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1016/j.clinthera.2018.02.011 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations